Does "Excessive" Anticoagulation Predispose to Periprosthetic Infection?

Journal of Arthroplasty

Volumn 22, Issue 6 SUPPL., 2007, Pages 24-28

  Parvizi, Javad ^a   Ghanem, Elie ^a   Joshi, Ashish ^a   Sharkey, Peter F ^a   Hozack, William J ^a   Rothman, Richard H ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

anticoagulation; hematoma; periprosthetic infection; total joint arthroplasty

Indexed keywords

ANTICOAGULANT AGENT; C REACTIVE PROTEIN; CEPHALOSPORIN; HEPARIN; WARFARIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTICOAGULATION; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEBRIDEMENT; DEMOGRAPHY; DISEASE PREDISPOSITION; FEMALE; HEMATOMA; HUMAN; INFECTION; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREVALENCE; PROSTHESIS; PROSTHESIS INFECTION; RISK FACTOR; SEPSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; WOUND; WOUND DRAINAGE; WOUND DRESSING;

AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CASE-CONTROL STUDIES; COMORBIDITY; HUMANS; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS;

EID: 34548258707     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2007.03.007     Document Type: Article

References (28)

1. Bauer T.W., Parvizi J., Kobayashi N., et al. Diagnosis of periprosthetic infection. J Bone Joint Surg Am 88 (2006) 869
2. Toms A.D., Davidson D., Masri B.A., et al. The management of peri-prosthetic infection in total joint arthroplasty. J Bone Joint Surg Br 88 (2006) 149
3. Leone J.M., and Hanssen A.D. Management of infection at the site of a total knee arthroplasty. J Bone Joint Surg Am 87 (2005) 2335
4. Garvin K.L., and Hanssen A.D. Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am 77 (1995) 1576
5. Phillips J.E., Crane T.P., Noy M., et al. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 88 (2006) 943
6. Hanssen A.D., and Rand J.A. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect 48 (1999) 111
7. Clohisy J.C., Calvert G., Tull F., et al. Reasons for revision hip surgery: a retrospective review. Clin Orthop Relat Res (2004) 188
8. Berbari E.F., Hanssen A.D., Duffy M.C., et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 27 (1998) 1247
9. Saleh K., Olson M., and Resig S. Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res 20 (2002) 506
10. Minnema B., Vearncombe M., Augustin A., et al. Risk factors for surgical-site infection following primary total knee arthroplasty. Infect Control Hosp Epidemiol 25 (2004) 477
11. Drancourt M., Argenson J.N., Tissot D.H., et al. Psoriasis is a risk factor for hip-prosthesis infection. Eur J Epidemiol 13 (1997) 205
12. Gordon S.M., Culver D.H., Simmons B.P., et al. Risk factors for wound infections after total knee arthroplasty. Am J Epidemiol 131 (1990) 905
13. Luessenhop C.P., Higgins L.D., Brause B.D., et al. Multiple prosthetic infections after total joint arthroplasty. Risk factor analysis. J Arthroplasty 11 (1996) 862
14. Trampuz A., Hanssen A.D., Osmon D.R., et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 117 (2004) 556
15. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 24 (1996) 380
16. Lavernia C., D'apuzzo M., Hernandez V.H., et al. Patient-perceived outcomes in thigh pain after primary arthroplasty of the hip. Clin Orthop Relat Res 441 (2005) 268
17. Lavernia C.J., Guzman J.F., and Gachupin-Garcia A. Cost effectiveness and quality of life in knee arthroplasty. Clin Orthop Relat Res (1997) 134
18. Jones C.A., Beaupre L.A., Johnston D.W., and Suarez-Almazor M.E. Total joint arthroplasties: current concepts of patient outcomes after surgery. Clin Geriatr Med 21 (2005) 527
19. Tate Jr. D., and Sculco T.P. Advances in total hip arthroplasty. Am J Orthop 27 (1998) 274
20. Barrack R.L., Engh G., Rorabeck C., et al. Patient satisfaction and outcome after septic versus aseptic revision total knee arthroplasty. J Arthroplasty 15 (2000) 990
21. Freeman M.A., Sudlow R.A., Casewell M.W., et al. The management of infected total knee replacements. J Bone Joint Surg Br 67 (1985) 764
22. Wang C.J., Huang T.W., Wang J.W., et al. The often poor clinical outcome of infected total knee arthroplasty. J Arthroplasty 17 (2002) 608
23. Vessely M.B., Whaley A.L., Harmsen W.S., et al. The Chitranjan Ranawat Award: long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties. Clin Orthop Relat Res 452 (2006) 28
24. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 338S
25. Colwell Jr. C.W., Collis D.K., Paulson R., et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am 81 (1999) 932
26. Fitzgerald Jr. R.H., Spiro T.E., Trowbridge A.A., et al. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am 83-A (2001) 900
27. Lawton R.L., and Morrey B.F. The use of heparin in patients in whom a pulmonary embolism is suspected after total hip arthroplasty. J Bone Joint Surg Am 81 (1999) 1063
28. Raghavan M., and Marik P.E. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest 127 (2005) 295